Products


API CAS NO Therapeutic Category
Donepezil Hcl 142057-77-0 Anti-Alzheimer’s Disease
Doxazosin Mesylate 77883-43-3 Anti-adrenergics
Montelukast Sodium 151767-01-1 Anti-inflammatory drugs
Olanzapine 132539-06-1 antipsychotics
Ondansetron Hcl 103639-04-9 antiemetics/antinauseants
Ondansetron 99614-02-5 antiemetics/antinauseants
Sumatriptan succinate 103628-46-2 Antimigraine
Ondansetron HCl dihydrate Antiemetics
Ondansetron base Antiemetics
Cetirizine Anti-histamines
Levocetirizine Anti-histamines
Etoricoxib Anti-inflammatory drugs
Hydroxychloroquine Anti-malarial agents
Umifenovir Anti-virals
Remdesivir Anti-virals
Rosuvastatin calcium Cardiovascular drugs
Olmesartan (intermediates) Cardiovascular drugs
Donepezil hydrochloride Neurologicals/Anti-Alzheimer's
Sumatriptan succinate Neurologicals/Anti-migraine agents
Olanzapine Form-I Neurologicals/Anti-psychotics
API Therapeutic Area Status
Levocetirizine HCl Antihistamine Technical Package
Cetirizine HCl Antihistamine Technical Package
Rosuvastatin calcium Antihyperlipidemic Technical Package
Etoricoxib Anti-inflammatory Under development
Lacosamide Neurologicals Under development
Mirabegron Anti-diuretic drugs Under development
Sitagliptin Antidiabetic Under development
Rivaroxaban Cardiovascular drugs Under development
Vildagliptin Anti-diabetic drugs Under development
Dabigatran Etexilate Antithrombotic agents Pipeline API
Ticagrelor Cardiovascular drugs Pipeline API
Dapagliflozin Antidiabetic Pipeline API
Macitentan Cardiovascular drugs Pipeline API
Linagliptin Antidiabetic Pipeline API
Canagliflozin Antidiabetic Pipeline API
Brivaracetam Anti-Epileptics Pipeline API
Tenofovir Alafenamide Fumarate Antivirals Pipeline API
Elagolix sodium Endocrine drugs
Nafamostat Anti-virals
Baloxavir marboxil Anti-viral drugs
Tenofovir alfenamide hemifumarate Anti-viral drugs
Intermediate CAS NO Type Therapeutic category
5-bromo-1-(2-fluoro-6-(trifluoromethyl)benzyl)-6-methylpyrimidine-2,4(1H,3H)-dione 830346-48-0 Elagolix Sodium intermediate Endometriosis
1-(4-chloro Benzhydryl) Piperazine 303-26-4 Cetirizine Dihydrochloride Intermediate Antihistamines
4-(4-Fluorophenyl)-6-isopropyl-2-[(N-methyl-n-methylsulfonyl)amino]pyrimidine-5-yl-methanol (Z-7) 147118-36-3 Rosuvastatin Intermediate Statins/Lipid regulators
N-[4-(4-Fluorophenyl)-5-formyl-6-(1-methylethyl)-2-pyrimidinyl]-N-methyl-methanesulfonamide (Z-8) 147118-37-4 Rosuvastatin Intermediate Statins/Lipid regulators
2-(2-(4-fluorophenyl)-2-oxo-1-phenylethyl)-4-methyl-3-oxo-N-phenyl pentanamide 125971-96-2 Atorvastatin Intermediate Statins/Lipid regulators
2-[(5-bromo-2-methylphenyl)methyl]-5-(4-fluorophenyl)thiophene 1030825-20-7 Canagliflozin Intermediate Antidiabetic
2-Amino thiophenol 137-07-5 CisLactam Antihypertensive
2-Chloro-4-amino-6,7-dimethoxyquinazoline 23680-84-4 Doxazosin Intermediate Antihypertensives

Conductive polymers

Name CAS NO Status
3,4-Ethylenedioxythiophene (EDOT) 126213-50-1 Commercialised
2-butyl-2,3-dihydrothieno[3,4-b]-1,4-dioxin (Butyl-EDOT) 552857-06-4 Commercialised

Derivatives

EDOT Derivatives CAS NO Status
Hydroxymethyl-EDOT 146796-02-3 Technical package
Chloromethyl-EDOT 857419-46-6 Technical package
Carboxy-EDOT 955373-67-8 Technical package
proDOT (propylenedioxythiophene) 155861-77-1 Technical package
TOP